Follow the Trials

1.On the western side of the Atlantic, conventional imaging1 remains standard of care (eg, magnetic resonance imaging or computed tomography of the abdomen/pelvis, bone scan). Although prostate-specific membrane antigen positron emission tomography is not yet FDA approved for primary high-risk prostate cancer, approval could happen soon. Positron emission tomography (choline, prostate-specific membrane antigen, or fluciclovine) can be performed...